|
Delayed
Nasdaq Stockholm
11:53:38 08/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 2.130 SEK | +1.43% |
|
+16.08% | +12.11% |
| 02/09 | Enzymatica CEO buys additional shares | FW |
| 02/09 | Enzymatica CEO buys 33 384 shares | FW |
| Market Cap | 510M 438M 412M 376M 704M 48.21B 706M 4.89B 1.89B 24.69B 1.91B 1.87B 78.64B | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 478M 411M 386M 353M 660M 45.17B 662M 4.58B 1.77B 23.13B 1.79B 1.75B 73.68B | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ENZY | Delayed | |
Deutsche Boerse AG
| EN9 | Delayed | |
|
Börse Stuttgart
| EN9 | Delayed | |
|
Boerse Muenchen
| EN9 | Real-time |
| 1 day | +1.43% | ||
| 1 week | +16.08% | ||
| Current month | +15.45% | ||
| 1 month | +11.81% | ||
| 3 months | -23.38% | ||
| 6 months | +7.04% | ||
| Current year | +12.11% |
| 1 week | 1.8 |  | 2.22 |
| 1 month | 1.65 | | 2.22 |
| Current year | 1.6 | | 3.4 |
| 1 year | 1.6 | | 3.4 |
| 3 years | 1.34 | | 5.45 |
| 5 years | 1.34 | | 12 |
| 10 years | 1.34 | | 24.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 01/02/2026 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 13/04/2026 |
| Chief Tech/Sci/R&D Officer | - | 27/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 15/02/2016 | |
Bengt Baron
CHM | Chairman | 64 | 19/12/2016 |
| Director/Board Member | 71 | 19/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/7/26 | Buy | Chief Financial Officer | 50,000 | 0.0206% | ||
| 1/4/26 | Sell | Responsable ventes & marketing | 40,000 | 0.0165% | ||
| 30/12/25 | Buy | Chairman | 20,000 | 0.0082% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.43% | +16.08% | -8.19% | -38.26% | 53.15M | |
| -1.98% | -2.86% | +52.56% | +92.15% | 1,024B | |
| -2.00% | -0.56% | +51.40% | +67.96% | 663B | |
| -2.56% | -3.38% | +19.73% | +68.56% | 453B | |
| -0.86% | +0.78% | +29.66% | +36.42% | 349B | |
| -10.44% | -13.79% | +10.34% | +28.12% | 295B | |
| -1.49% | -0.14% | -0.20% | +10.14% | 253B | |
| -9.13% | -8.52% | +43.04% | +54.49% | 236B | |
| -2.07% | -0.37% | -15.61% | -56.79% | 206B | |
| -2.78% | -1.86% | +26.97% | +93.59% | 187B | |
| Average | -3.12% | +2.43% | +20.97% | +35.64% | 366.74B | |
| Weighted average by Cap. | -3.01% | +0.52% | +33.33% | +58.04% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 45.58M 39.19M 36.86M 33.65M 62.94M 4.31B 63.14M 437M 169M 2.21B 171M 167M 7.03B | 53.9M 46.36M 43.6M 39.8M 74.44M 5.1B 74.68M 517M 200M 2.61B 202M 198M 8.32B |
| Net income | -53.18M -45.73M -43.01M -39.27M -73.44M -5.03B -73.67M -510M -197M -2.58B -200M -195M -8.2B | -51.89M -44.63M -41.97M -38.31M -71.66M -4.91B -71.89M -498M -192M -2.51B -195M -191M -8B |
| Net Debt | -73.01M -62.79M -59.06M -53.91M -101M -6.9B -101M -700M -271M -3.54B -274M -268M -11.26B | -32.11M -27.62M -25.97M -23.71M -44.34M -3.04B -44.49M -308M -119M -1.56B -121M -118M -4.95B |
Employees
18
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/09/26 | SEK 2.130 | +1.43% | 125,392 |
| 07/09/26 | SEK 2.100 | +3.96% | 149,511 |
| 04/09/26 | SEK 2.020 | 0.00% | 118,324 |
| 03/09/26 | SEK 2.020 | +9.19% | 237,957 |
| 02/09/26 | SEK 1.850 | +0.82% | 116,529 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- ENZY Stock
Select your edition
All financial news and data tailored to specific country editions
